---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-027293"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2024-02-26T23:59:59+00:00"
generated_at: "2026-06-05T14:31:26.044704+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics enters $750K manufacturing deal with director-owned CDMO Cell Ready

## Summary
- 3-year Master Services Agreement with Cell Ready LLC, owned by director/shareholder John Wilson.
- Work Order #1 for GMP drug product for MT-401 and/or MT-601; projected sum ≤$750K for Q1 2024.
- Agreement includes customary reps, warranties, and indemnification; either party may terminate for breach or insolvency.
- Additional work orders expected for the remainder of 2024.

## SEC filing metadata
- accession: 0001104659-24-027293
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2024-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465924027293/0001104659-24-027293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465924027293/tm247177d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-027293
- JSON: https://secwatch.observer/filing/0001104659-24-027293.json
- Plain text: https://secwatch.observer/filing/0001104659-24-027293.txt

## Key facts
- Material Agreements
  Marker Therapeutics, Inc. entered into Master Services Agreement for Product Supply with Cell Ready LLC valued at $750,000 (effective 2024-02-22).
  - Action: entry
  - Agreement: supply
  - Counterparty: Cell Ready LLC
  - Value: $750,000
  - Effective: 2024-02-22
  source text: (the “Company”) entered into a Master Services Agreement for Product Supply (the “Agreement”) with Cell Ready LLC (“Cell Ready”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465924027293/0001104659-24-027293-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.